Research

rs2277339 — PRIM1 PRIM1 Asp5Ala missense variant

Missense variant in PRIM1 (DNA primase small subunit) that changes aspartate to alanine at position 5 of the protein; the G allele (Asp5Ala) is associated with later age at natural menopause by approximately 0.35 years per copy, implicating DNA replication priming fidelity in the rate of ovarian follicle depletion

Strong Protective Share

Details

Gene
PRIM1
Chromosome
12
Risk allele
T
Clinical
Protective
Evidence
Strong

Population Frequency

GG
1%
GT
20%
TT
78%

See your personal result for PRIM1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

PRIM1 rs2277339 — A DNA Primase Variant Linked to Extended Ovarian Lifespan

Every cell in your body replicates approximately 6 billion base pairs of DNA during each division cycle. Before a new DNA strand can be synthesised, a molecular machine called DNA primase11 DNA primase
the enzyme complex that synthesises short RNA primers, providing the 3'-OH ends that DNA polymerase requires to begin copying the template
must first lay down short RNA primers at thousands of sites. PRIM1 encodes the small catalytic subunit of this primase — the component that directly synthesises those primers. A single amino acid change at position 5 of the protein, converting aspartate to alanine (p.Asp5Ala), is associated with measurably later age at natural menopause. The cells most vulnerable to primase function are the primary oocytes arrested in meiosis for decades, relying on intact DNA replication and repair machinery to survive.

Note on nomenclature: rs2277339 has two alternate alleles. The G allele (plus-strand, causing p.Asp5Ala) is the common GWAS-significant variant at approximately 11% frequency in Europeans. A second alternate A allele (causing p.Asp5Val) is essentially absent from population databases (≈0% gnomAD); it is not the variant studied in reproductive aging cohorts and is not covered by the interpretations below.

The Mechanism

PRIM1 encodes the 49 kDa catalytic subunit of the heterodimeric primase complex. It directly catalyses RNA primer synthesis de novo — the only step in eukaryotic DNA replication that does not require a pre-existing 3'-OH terminus. The p.Asp5Ala substitution falls within the N-terminal region of the protein, near conserved residues that participate in template binding and catalytic metal coordination. Asp residues at or near the active site of primases are generally involved in coordinating the two divalent metal ions (Mn²⁺ or Mg²⁺) required for nucleotide polymerisation. An Ala substitution at position 5 likely modestly alters the geometry of the catalytic centre rather than abolishing activity outright — consistent with the fact that the G allele is common (11%) and associated with a quantitative shift in menopause timing rather than a Mendelian ovarian failure syndrome.

[Primary oocytes | eggs that have been arrested in the first division of meiosis since before birth, and must wait — sometimes for 40+ years — until recruited into a growing follicle] depend on efficient DNA replication during oocyte growth and on accurate repair of the double-strand breaks introduced intentionally during meiotic recombination. Errors in either process can trigger apoptotic elimination of the affected oocyte, permanently reducing the functional follicle pool. Genome-wide studies of age at natural menopause have consistently over-represented DNA replication and damage-response genes among the top hits22 Genome-wide studies of age at natural menopause have consistently over-represented DNA replication and damage-response genes among the top hits
Ruth et al. 2021 mapped 290 determinants of ovarian ageing, the majority converging on the DNA damage response
, which makes the primase gene a biologically coherent candidate.

Telomere maintenance is a second relevant pathway. Telomeres are replicated by a specialised mechanism that still requires primase activity for lagging-strand synthesis of the complementary strand. Shortened or dysfunctional telomeres in granulosa cells and oocytes accelerate follicle loss; a subtle impairment in primase catalysis could disproportionately affect the telomere-adjacent sequences where replication efficiency is already reduced.

The Evidence

The primary evidence comes from two large genome-wide association studies.

Stolk et al. 201233 Stolk et al. 2012
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nature Genetics, 44:260–268
conducted a meta-analysis of 22 GWAS including 38,968 European women, with replication in up to 14,435 additional women. The study identified 13 novel genome-wide significant loci for age at natural menopause; PRIM1 was one of eight candidate genes explicitly implicated in DNA damage response and repair. The enrichment of DNA-repair loci was statistically striking — PRIM1, TLK1, HELQ, EXO1, UIMC1, FAM175A, FANCI, and POLG all reached genome-wide significance, pointing to a shared biological bottleneck in oocyte DNA maintenance as a key determinant of ovarian lifespan.

Ruth et al. 202144 Ruth et al. 2021
Genetic insights into biological mechanisms governing human ovarian ageing. Nature, 596:393–397
extended this work to approximately 200,000 women of European ancestry, identifying 290 genetic determinants of ovarian ageing. PRIM1 rs2277339 was among the top coding missense variants in that study, with the G allele associated with approximately 0.354 years (about 18 weeks) later natural menopause per allele copy. Women with the highest polygenic burden for late menopause reached a risk profile comparable to carriers of FMR1 premutations — a known cause of premature ovarian insufficiency — illustrating how multiple modest GWAS loci accumulate to clinically meaningful shifts.

A maternal genotyping study by Chan et al. 202355 maternal genotyping study by Chan et al. 2023
Maternal polymorphisms of meiosis and DNA damage repair genes and fetal chromosomal stability. J Perinat Med, 51:1082–1096
examined rs2277339 alongside seven other DNA repair variants in 571 women carrying foetuses with chromosomal abnormalities versus 811 controls. Significant genotype differences were found for PRIM1 rs2277339 (p=0.008) specifically in the advanced maternal age subgroup with fetal aneuploidy — suggesting that PRIM1 primase function may influence not only the timing of follicle depletion but also the fidelity of meiotic chromosome segregation in ageing oocytes.

Population specificity: a Sanger sequencing study of 192 Chinese women with primary ovarian insufficiency66 Sanger sequencing study of 192 Chinese women with primary ovarian insufficiency
Wang et al. 2016, Reprod Biomed Online
found no coding PRIM1 mutations contributing to POI in that cohort, and prior GWAS signals at rs2277339 did not replicate in East Asian women. This likely reflects that rs2277339 is a tag SNP in linkage disequilibrium with the causal variant in European-ancestry populations but not in East Asian LD blocks — rather than a true absence of PRIM1 biology in non-European ovaries. The G allele frequency in East Asian populations (~22%) is actually higher than in Europeans (~10.5%), reinforcing that frequency alone cannot distinguish causal from tag SNPs.

Practical Actions

Each G allele at rs2277339 shifts expected menopause onset approximately 0.35 years (about 18 weeks) later in the population-average sense. For TT individuals — by far the most common genotype (~78% of people) — menopause timing from this locus is at the baseline. For TG carriers (~20% of people), the G allele provides a modest delay. The GG genotype (~1.4%) provides the greatest average delay.

The clinical implication runs in the opposite direction from most risk-oriented SNPs: this variant, in its G-allele form, represents a slight protective signal for ovarian lifespan. For TT individuals without G-allele protection, ovarian reserve monitoring from a DNA-repair perspective follows standard clinical guidance rather than an elevated-risk protocol.

Because PRIM1 primase function is linked to DNA replication accuracy during oocyte growth phases, interventions that reduce oxidative DNA damage in the ovary are mechanistically relevant across all genotypes — but are most directly applicable to the TT baseline group who lack the extended-primase-efficiency benefit conferred by the G allele.

Interactions

PRIM1 rs2277339 operates within a network of DNA-damage-response and replication loci that were all simultaneously identified in the Stolk 2012 and Ruth 2021 GWAS. The most relevant partners in the GeneOps database are:

rs10183486 (TLK1) — Tousled-like kinase 1 phosphorylates the Asf1 histone chaperone during DNA replication and repair. TLK1 and PRIM1 work in adjacent stages of the same replication fork: PRIM1 synthesises the primer, and TLK1-Asf1 packages the newly synthesised DNA into chromatin. Women carrying T alleles at rs10183486 (earlier menopause risk) and also lacking G alleles at rs2277339 (baseline primase efficiency) may have a compound disadvantage in oocyte DNA maintenance, though no published analysis has formally tested this combination.

rs16991615 (MCM8) — MCM8 is a helicase essential for homologous recombination repair of meiotic double-strand breaks. Like PRIM1, it emerged from the same GWAS wave and is associated with age at natural menopause and AMH levels. The MCM8–PRIM1 pair represents convergent failure points in the replication–repair continuum.

Genotype Interpretations

What each possible genotype means for this variant:

TT Normal

Baseline PRIM1 primase function — standard ovarian aging trajectory at this locus

The TT genotype means you carry no copies of the G allele (Asp5Ala) that the Stolk 2012 and Ruth 2021 GWAS studies associated with later menopause timing. Your PRIM1 primase activity at the catalytic N-terminal region is unmodified relative to the ancestral sequence. This does not imply impaired primase function — TT is the wild-type state and the most common configuration in all studied populations.

Standard determinants of ovarian reserve (AMH, antral follicle count, FSH) and lifestyle factors remain the most important determinants of your individual reproductive timeline. The absence of the G allele simply means you do not carry this particular protective variant; your trajectory at this locus is average, not elevated-risk.

GG “Two G alleles — strongest PRIM1 primase benefit” Beneficial

Two copies of the G allele — associated with latest expected menopause timing at this locus

GG homozygosity places you at the most protective end of the rs2277339 distribution for ovarian aging. The effect is additive — two G alleles confer approximately twice the individual G-allele benefit seen in the Stolk 2012 and Ruth 2021 datasets. At a molecular level, all expressed PRIM1 protein carries the Ala5 variant, meaning any catalytic or structural advantage from this substitution is fully expressed without dilution from wild-type Asp5 protein.

Because GG homozygotes are rare (~1.4% globally), effect size estimates for this specific genotype carry wider confidence intervals than those for TG heterozygotes. The 0.7-year delay estimate is an extrapolation from the additive per-allele beta; in practice, individual variation is large. Ovarian reserve testing (AMH) provides more direct information about your current follicle pool than any genotype-based estimate.

The Chan 2023 finding — that rs2277339 genotype differences were significant specifically in older mothers with fetal aneuploidy (p=0.008) — may suggest that GG carriers have additional protection against the meiotic errors that generate chromosomally abnormal embryos, though this requires confirmation in larger cohorts.

GT “One G allele — modest PRIM1 primase variant” Beneficial

One copy of the G allele — modestly associated with later natural menopause

The p.Asp5Ala substitution alters a residue near the catalytic centre of the PRIM1 subunit. The heterozygous state means roughly half of your PRIM1 protein carries the Ala5 variant and half carries wild-type Asp5. The net effect is a modest, additive shift toward later menopause in population studies — approximately 18 weeks per allele based on the Ruth 2021 (~200,000 women) dataset.

The biological interpretation is that the Ala5 variant slightly alters primase catalytic geometry in a way that may improve oocyte DNA replication fidelity or telomere maintenance efficiency — though the molecular mechanism has not been directly tested in human oocytes. The association with fetal chromosomal stability in older mothers (Chan 2023, p=0.008) is consistent with a role in meiotic accuracy beyond simple follicle count.

This is a mild signal at one locus; dozens of other genetic and environmental factors shape your actual age at menopause more powerfully than a single copy of this variant.